Eric Holland, Director of the Brain Tumor Center, is a neurosurgeon and researcher who studies the molecular changes that occur in glioblastoma and other brain tumors.

Our Employee Survivorship Program supports staff members being treated for cancer and those who have completed therapy.

Thoracic surgeon Inderpal Sarkaria discusses the expertise of Memorial Sloan-Kettering surgeons at performing complex operations to treat cancers of the lung, esophagus, and chest wall.

New studies investigate how the use of antibiotics affects the balance of both harmful and beneficial bacteria in patients undergoing stem cell transplantation.

Memorial Sloan-Kettering’s trial to evaluate a new therapy for patients with beta-thalassemia is the first to receive FDA approval to treat this disease with genetically engineered cells.

At Memorial Sloan-Kettering, an experienced team of physicians, nurses, and support staff care for children with the rare eye cancer retinoblastoma and their families.

A team of investigators from Memorial Sloan-Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells.